$27.03
Price
$1.6B
Market Cap
—
P/E Ratio
-11.4
Forward P/E
$-1.81
EPS (TTM)
—
Dividend Yield
$478M
Cash
—
Total Debt
59M
Shares Out
$13.30
$29.98
52-Week Range
Institutional Ownership of Enliven Therapeutics, Inc.
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Enliven Therapeutics, Inc.
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for Enliven Therapeutics, Inc.
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.